The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $59.60

Today's change0.00 0.00%
Updated June 27 4:02 PM EDT. Delayed by at least 15 minutes.
 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $59.60

Today's change0.00 0.00%
Updated June 27 4:02 PM EDT. Delayed by at least 15 minutes.

Cambrex Corp closed at (U.S.)$59.60.

Over the last five days, shares have gained 0.34% and 10.47% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $60.50
  • Previous close(U.S.) $59.60
  • High(U.S.) $60.60
  • Low(U.S.) $59.45
  • Bid / Ask-- / --
  • YTD % change+10.47%
  • Volume227,045
  • Average volume (10-day)256,954
  • Average volume (1-month)247,493
  • Average volume (3-month)307,443
  • 52-week range(U.S.) $38.30 to (U.S.) $62.95
  • Beta2.27
  • Trailing P/E21.08×
  • P/E 1 year forward19.75×
  • Forward PEG1.32×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.83
Updated June 27 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue10517899119
Total other revenue--------
Total revenue10517899119
Gross profit47793849
Total cost of revenue58996270
Total operating expense781218088
Selling / general / administrative16181514
Research & development4334
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--1----
Other operating expenses, total--------
Operating income27571931
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax27561931
Income after tax21381421
Income tax, total618510
Net income2037920
Total adjustments to net income--------
Net income before extra. items21381421
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items21381421
Inc. avail. to common incl. extra. items2037920
Diluted net income2037920
Dilution adjustment--0----
Diluted weighted average shares33333333
Diluted EPS excluding extraordinary itemsvalue per share0.631.150.420.63
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.631.170.420.63